Early research (Phase 1)Study completedNCT01900587
What this trial is testing
A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet
Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64